Proteomics

Dataset Information

0

First penicillin-binding protein occupancy patterns for 15 β-lactams and β-lactamase inhibitors in Mycobacterium abscessus


ABSTRACT: Mycobacterium abscessus (Mab) causes serious infections that often require over 18 months of antibiotic combination therapy. With β lactam antibiotics being safe, double β-lactam and β-lactam/β-lactamase inhibitor combinations are of interest for improving treatment of Mab infections and minimizing toxicity. However, a mechanistic approach for building these combinations is lacking since little is known about which penicillin-binding protein (PBP) target receptors are inactivated by different β-lactams in Mab. This project aimed to identify PBPs in Mab and study the binding affinities of each of these PBPs with β-lactam antibiotics. These first PBP occupancy patterns in Mab provide a mechanistic foundation for selecting and optimizing safe and effective combination therapies with β-lactams.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Mycobacterium Abscessus (strain Atcc 19977 / Dsm 44196 / Cip 104536 / Jcm 13569 / Nctc 13031 / Tmc 1543)

SUBMITTER: Yinzhi Lang  

LAB HEAD: Jürgen B. Bulitta

PROVIDER: PXD022644 | Pride | 2020-11-24

REPOSITORIES: Pride

altmetric image

Publications

First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus.

Sayed Alaa R M ARM   Shah Nirav R NR   Basso Kari B KB   Kamat Manasi M   Jiao Yuanyuan Y   Moya Bartolome B   Sutaria Dhruvitkumar S DS   Lang Yinzhi Y   Tao Xun X   Liu Weiguo W   Shin Eunjeong E   Zhou Jieqiang J   Werkman Carolin C   Louie Arnold A   Drusano George L GL   Bulitta Jürgen B JB  

Antimicrobial agents and chemotherapy 20201216 1


<i>Mycobacterium abscessus</i> causes serious infections that often require over 18 months of antibiotic combination therapy. There is no standard regimen for the treatment of <i>M. abscessus</i> infections, and the multitude of combinations that have been used clinically have had low success rates and high rates of toxicities. With β-lactam antibiotics being safe, double β-lactam and β-lactam/β-lactamase inhibitor combinations are of interest for improving the treatment of <i>M. abscessus</i> i  ...[more]

Publication: 1/2

Similar Datasets

2023-08-23 | PXD034831 | Pride
2021-09-09 | PXD021675 | Pride
2021-09-09 | PXD021727 | Pride
2022-07-01 | GSE207144 | GEO
2013-05-20 | GSE43759 | GEO
| PRJNA704789 | ENA
| PRJNA566319 | ENA
2008-09-30 | GSE9308 | GEO
| PRJNA563513 | ENA
| PRJNA543210 | ENA